Bumrungrad Hospital PCL
SET:BH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
204
278
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bumrungrad Hospital PCL
Bumrungrad Hospital PCL
Cost of Revenue
Bumrungrad Hospital PCL
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bumrungrad Hospital PCL
SET:BH
|
Cost of Revenue
-฿12.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
Cost of Revenue
-฿67.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
C
|
Chularat Hospital PCL
SET:CHG
|
Cost of Revenue
-฿6.2B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bangkok Chain Hospital PCL
SET:BCH
|
Cost of Revenue
-฿8.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
Cost of Revenue
-฿6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
R
|
Ramkhamhaeng Hospital PCL
SET:RAM
|
Cost of Revenue
-฿7.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-13%
|
|
Bumrungrad Hospital PCL
Glance View
Bumrungrad Hospital PCL, often regarded as a leader in the healthcare sector in Thailand, has successfully crafted a narrative of excellence and innovation since its establishment in 1980. Located in Bangkok, this world-class hospital caters not only to local patients but also attracts a considerable number of international medical tourists, establishing itself as a premier destination for high-quality healthcare services in Asia. With advanced medical technology, a comprehensive range of services, and a highly skilled team of physicians, Bumrungrad continuously enhances its appeal, making it an attractive investment opportunity for those looking to enter the burgeoning healthcare market. As an investor, one cannot overlook the hospital's impressive financial performance showcased through steady revenue growth, driven by its diverse patient base and commitment to quality care. The company has strategically positioned itself to capitalize on the rising demand for healthcare services, particularly among foreign patients seeking specialized treatments that might not be available in their home countries. Furthermore, Bumrungrad Hospital’s focus on innovation, such as implementing state-of-the-art telemedicine and digital health solutions, promises not only to enhance patient experience but also to improve operational efficiencies. In a rapidly changing healthcare landscape, Bumrungrad stands out as a robust investment, offering the potential for long-term growth and sustainable returns.
See Also
What is Bumrungrad Hospital PCL's Cost of Revenue?
Cost of Revenue
-12.6B
THB
Based on the financial report for Sep 30, 2024, Bumrungrad Hospital PCL's Cost of Revenue amounts to -12.6B THB.
What is Bumrungrad Hospital PCL's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%
Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Bumrungrad Hospital PCL have been -20% over the past three years , -4% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
